Author Bio Matt is a Certified Financial Planner based in South Carolina who has been writing for The Motley Fool since 2012. Matt specializes in writing about bank stocks, REITs, and personal finance, but he loves any investment at the right price. Follow him on Twitter to keep up with his latest work! Follow @TMFMathGuy The need for life science properties is growing exponentially in the United States -- and not just for developing COVID-19 vaccines and treatments. Innovation in the healthcare industry has never been more active, and the need for state-of-the art properties to conduct research and development is increasing.